Skip to content

Efficacy and safety of remazolam for postoperative sedation in patients undergoing maxillofacial flap surgery: a randomized, control study.

Efficacy and safety of remazolam for postoperative sedation in patients undergoing maxillofacial flap surgery: a randomized, control study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048342
Enrollment
Unknown
Registered
2021-07-05
Start date
2021-07-12
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sedation

Interventions

Dexmedetomidine group:Dexmedetomidine

Sponsors

Peking University Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 to 80 years (exclude 80); 2.Patients who planned to undergo elective maxillofacial surgery for mass resection and free tissue flap repair; 3.Postoperative preventive tracheotomy was not performed, and endotracheal intubation was retained; 4.Voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with bradycardia before surgery (ecg heart rate = grade IV; 7.Known allergy to a2 agonists, rimazolam, or other benzodiazepines.

Design outcomes

Primary

MeasureTime frame
Incidence of posoperative agitation in post-anesthesia care unit (PACU);

Secondary

MeasureTime frame
Incidence of delirium within the first 5 days after surgery;Severity of pain at postoperative 6, 12, 24 h;Incidence of postoperative nausea and vomiting;Length of stay in hospital after surgery;Incidence of in-hospital other complications and all-cause in-hospital mortality after surgery;

Countries

China

Contacts

Public ContactYang Xudong

Peking University Hospital of Stomatology

kqyangxudong@163.com+86 18810086060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026